Trinity matches that standard with brand-name FDA-approved prescriptions and clinically supervised compounded options from PCAB/NABP-accredited pharmacies
Between the Kaiser Family Foundation, employer coalitions such as the Business Group on Health, and benefit consulting firms such as Mercer, PwC, and Willis Towers Watson, theres a wealth of annually updated information out there
The pivotal 2021 clinical trial of semaglutide revealed that nearly 14% of participants were unable to lose even 5% of their body weight, despite being on the medication for over a year
Quick Answer: Most patients require long-term GLP-1 therapy because diabetes and obesity are chronic conditions, and discontinuation typically causes weight regain and worsening blood sugar control
Most users report significant improvement when combining increased water intake with electrolyte supplementation
Retatrutide-A Game Changer in Obesity Pharmacotherapy